$$$ UDTT - CEO kauft 100,000,000 Aktien ! $$$
Universal Detection Technology's BSM-2000 Anthrax Detector Approved for Listing on Department of Homeland Security Sponsored Database for Products Serving First Responders
Anthrax Detector Listed on Responder Knowledge Base at WWW.RKB.US
LOS ANGELES, CA--(Marketwire - February 1, 2008) - Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that its BSM-2000 Anthrax Detection System was listed on the Responder Knowledge Base (RKB) website, the Primary source of information for First Responders. The site is sponsored by the Department of Homeland Security.
The Responder Knowledge Base (RKB) website was created to provide emergency responders, purchasers, and planners with a trusted, integrated, on-line source of information on products, standards, certifications, grants, and other equipment-related information. The RKB is funded through the FEMA National Preparedness Directorate, U.S. Department of Homeland Security (DHS). This is part of Universal Detection Technology's strategy to provide its biodetection solutions directly to the first responder community that would be charged with responding to a biological incident.
"The listing on the RKB website will allow first responders throughout the country to access and review information on the BSM-2000 as it relates to the detection of bacterial spores such as anthrax. We are pleased to continue our work with the Nation's first responders," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer. "We plan to continue to list all our products on the site giving first responders access to our whole spectrum of CBRN detection products," he added.
UDTT is a supplier of counter-terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.
For more information please visit www.udetection.com or
Email us at info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
Und damit Ende!
ax
wie hoch ist der verlust wenn man einsteigt?
Feb 26, 2008 07:00 ET
Universal Detection Technology Comments on Recently Reported Fatality Caused by MRSA Induced Pneumonia
Universal Detection Technology's Anti-Microbial Product Line Designed to Eliminate MRSA
LOS ANGELES, CA--(Marketwire - February 26, 2008) - Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, commented today on the recent report of a fatality caused by Methicillin-resistant Staphylococcus (MRSA) induced pneumonia of a student at Western Washington University. UDT recently launched a new hub for online sales and marketing of anti-microbial products that eliminate harmful bacteria such as MRSA.
The 20-year-old student was admitted to the intensive care unit at St. Joseph Hospital in Washington on February 14th after experiencing two weeks of coughing that progressed to fever, vomiting and coughing up blood. Doctors gave him antibiotics, but they were unable to help the young man, who eventually died.
Pneumonia caused by MRSA is a recent phenomenon, only being recognized as a confirmed strain 5 years ago. Adding to this growing concern is the fact that over the last number of years the MRSA bug has been moving out of nursing home and hospital settings and into public places such as schools. This is the second reported death of a student from MRSA in the last year. MRSA is responsible for more than 94,000 serious infections and nearly 19,000 deaths each year.
"The recent spread of MRSA to schools is very alarming," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer. "Our line of anti-microbial products consisting of various sprays, foggers and detergents are designed to eliminate surfaces and keep them sterile for a period following application," he added.
For ordering Anti-Microbial Products Please visit www.antimicrobialproduct.com.
For more information please visit www.udetection.com or
Email us at info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
Contact:
Universal Detection Technology
Jacques Tizabi
310-248-3655
Email Contact
UDTT Initiates Marketing of Anti-MRSA Products Approved by the Environmental Protection Agency, EPA
http://www.finanznachrichten.de/ext/goto.asp?id=10224046
29.02.08:
UDTT's Analysis of the Recent Ricin Incident in Las Vegas
http://www.finanznachrichten.de/ext/goto.asp?id=10240070
Leider sind die sog. Verkäufe einfach bis dato zu gering, halt mehr oder minder Testorders. ... und jedes Mal gibt s ne große Pressemitteilung dazu.
Das ist so, als wenn ein Kaffeeladen bei jedem verkaufen Pfund Kaffee ein Riesengetöse machen würde.
.... aber, da ja ein paar Euros von mir drinstecken, muss ich ja nu positiv denken ;-) und immer noch besser so, als null Nachrichten, wie bei meinem 2. Desaster Habanero, bei denen sich aber in den letzten Wochen die Insider (www.canadieninsider.com) eingedeckt haben.
http://www.sec.gov/Archives/edgar/data/763950/...on_10kext-123107.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One)
[X] Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ ] Form 10-QSB
[ ] Form N-SAR [ ] Form N-CSR
For Period Ended: December 31, 2007
-----------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ________________________
+-------------------------------------------------
| |
|Read Instruction (on back page) Before Preparing Form. Please Print or Type. |
| |
| Nothing in this form shall be construed to imply that the Commission has |
| verified any information contained herein. |
--------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
UNIVERSAL DETECTION TECHNOLOGY
--------------------------------------------------
Full Name of Registrant:
--------------------------------------------------
Former Name if Applicable
9595 WILSHIRE BOULEVARD, SUITE 700
--------------------------------------------------
Address of Principal Executive Office (Street and Number)
BEVERLY HILLS, CA 90212
--------------------------------------------------
City, State, Zip Code
PART II - RULES 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be
[X] filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report of transition report on Form
10-QSB, or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR or the transition report or portion thereof could not be filed
within the prescribed time period. (Attach extra sheets if needed.)
The company has experienced a delay in completing the information necessary to
include in its December 31, 2007 form 10-KSB Annual Report (the "Annual
Report"). The Company expects to file the annual report within the allotted
extension period.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Mark Abdou, Esq. (310) 208-1182
---------------------------- ----------------- ---------------
(Name) (Area Code) (Telephone No.)
(2) Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is
no, identify report(s). [X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof? [ ] Yes [X] No
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
UNIVERSAL DETECTION TECHNOLOGY
------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 26, 2008 By: /s/ Jacques Tizabi
----------------------------- -------------------------------------
Chief Executive Officer
INSTRUCTION; The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. if the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
http://www.finanznachrichten.de/ext/goto.asp?id=10437186
Universal Detection Technology Receives Purchase Order for Anti MRSA Products From Chinese Distributor
Partner in China, With the Highest Rate of Antibiotic Resistant Bacteria, to Purchase Anti Microbial Chemical
LOS ANGELES, March 27, 2008 (PRIME NEWSWIRE) -- Universal Detection Technology (www.udetection.com) (OTCBB:UDTT) (Frankfurt:PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, and provider of counter-terrorism consulting and training services, announced today that it has received a purchase order for anti MRSA products from its Chinese distributor. The purchase order has been placed by Kadinuo Science and Technology in Beijing, China.
Kadinuo Science and Technology has been active in introduction and promotion of advanced radiation instruments in the Chinese market for over 10 years. Presently, the company is a strong regional supplier of emergency nuclear monitors, environmental radiation monitors, decontamination technologies, and the like.
"This is the second purchase order we have received from our Chinese distributor pursuant to our recent agreement. The first order was related to our line of bioterrorism detection products. We look forward to establishing an effective and long term relationship with Kadinuo and to use their influence to find a market for our products and services in China both in the counter-terrorism market and in the anti-microbial market," said Mr. Jacques Tizabi, UDTT's Chairman and CEO.
Studies show that China has the highest rate of antibiotic resistant bacteria strains in the world. The World Health Organization West Pacific Regional Office has set up two antimicrobial resistance surveillance centers in Beijing and Shanghai. Data from the offices show the prevalence of both hospital-acquired and community-acquired MRSA strains in both cities. Moreover, the breakout of Severe Acute Respiratory Syndrome (SARS) in the spring of 2003 illustrates how an infectious disease with limited therapeutic options can spread rapidly across national borders. Rapidly increasing travel and migration within China probably contributes to the growth of that nation's resistance problem. It may also spur the spread of China's resistance problems overseas as globalization greatly increases travel from and to that nation.
UDTT is a supplier of counter terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.
For more information please visit www.udetection.com or Email us at info@udetection.com
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
CONTACT: Universal Detection Technology
Jacques Tizabi
310-248-3655
Apr 22, 2008 16:00 ET
Universal Detection Technology Receives Purchase Order for Hand Held Assays From Israeli Company
Hand Held Assays Used for Detection of Anthrax Sold to Israeli Company
LOS ANGELES, CA--(Marketwire - April 22, 2008) - Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter terrorism training and solutions, announced today that it has received a purchase order from an Israeli company for Company's Hand Held Assays (HHA).
The Israeli government as well as private security firms are actively improving their preparedness for a bioterror attack as the potential threat of such an attack from terror organizations and states with active biological weapon programs, such as Syria, grows. As an example, large numbers of the Israeli population have received smallpox inoculations.
UDTT's anthrax detection HHAs have provided accurate results to users in the field in as little as three minutes. The assays have been purchased by first responders throughout the country as well as the U.S. Army. The kits are able to detect anthrax spores well below the threshold for an infectious dose.
"We have seen increased interest in our bioterrorism detection kits recently from Israeli security firms and we hope that this trend can open up doors to more international sales of UDTT's HHAs," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer.
For more information please visit our website at www.udetection.com or
Email us at info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
Contact:
Jacques Tizabi
310-248-3655
Email Contact
Apr 25, 2008 16:00 ET
Article by Universal Detection Technology Featured in the Counter Terrorist Magazine
Article Titled "Combating the Evolving Threat of Biological Terrorism," by Universal Detection Technology Published in Industry Publication
LOS ANGELES, CA--(Marketwire - April 25, 2008) -
Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter terrorism training and solutions, announced today that a recent article titled "Combating the Evolving Threat of Biological Terrorism" drafted by UDTT's Director of Research and Development, Mr. Amir Ettehadieh has been published in the Counter Terrorist Magazine.
The Article describes the bio-terrorist threat facing the nation from both homegrown and foreign terrorist elements and the necessary steps that need to be taken by the government to combat this lethal WMD threat.
Unlike other weapons of mass destruction, biological agents used as a weapon of war are easy to conceal, easy to release, and designed to cause the simultaneous infection of mass casualties. The Nation must therefore be able to prepare for and respond to the evolving threat of bioterrorism and react to all manner of mass casualty incidents as effectively and efficiently as possible.
The three biggest life threatening Bio-terror scenarios that arguably pose the greatest threats to humans are a smallpox attack, an airborne anthrax attack, and a release of botulinum toxin in particular the milk supply.
The Anthrax mailings of 2001 were the most recent bio-terror attack involving weaponized anthrax. It is widely believed that the anthrax mailings were work of a domestic terrorist with access to advanced bio-weapon manufacturing equipment. Prior to that, the Aum Shinrikyo cult in Japan attempted an anthrax release in Tokyo in 1995 that did not cause any casualties due to the less virulent strain of anthrax used. Most disturbing is Al-Qaeda's pursuit of biological weapons evidence of which was uncovered in safe houses in Afghanistan.
The government currently has programs such as Project Bio-watch to monitor the air in large metropolitan areas as well as equipment in place to scan mail for bio-weapons. However, these programs need to be upgraded to allow for more rapid detection of an attack as well as being able to detect modified and more virulent stains of bio-weapons.
UDTT is a supplier of counter terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.
For more information please visit our website at www.udetection.com or
Email us at info@udetection.com.
About the Counter Terrorist Magazine
With a reputation forged by hard work and determination to empower Homeland Security warriors, The Counter Terrorist magazine is America's premier informational journal for Homeland Security professionals. The magazine's mission is to provide first responders relevant technical information they need to combat terrorism at home and abroad. The Counter Terrorist's aim is nothing short of our country's motto regarding the war on terror: Be Ready. The magazine feautures articles, reviews and subject matter experts on such relevant topics as: The radical Islamic threat, Internet jihad infrastructure, mass casualty protection, school shooting, threat assessments, and the like. For more information, please go to: http://www.thecounterterroristmag.com/.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain bio hazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
Contact:
Jacques Tizabi
310-248-3655
Email Contact
26.04.08 8:57
US-Regierung warnt vor erhöhter Terrorgefahr in China
Washington. sda/reuters/afp/baz. Die US-Regierung hat vor Terroranschlägen bei den Olympischen Spielen in Peking gewarnt. Das Aussenministerium in Washingten gab am Freitag eine Reisewarnung für die Volksrepublik heraus.
«Es besteht ein erhöhtes Risiko, dass extremistische Gruppen in China in der näheren Zukunft Terrorakte ausführen werden», erklärte das Aussenministerium. Grosse öffentliche Veranstaltungen wie die Olympischen Spiele könnten ein «attraktives Ziel für Terroristen» bieten.
US-Bürger, die in China lebten oder dort hinreisten, sollten insbesondere in Hotels, Restaurants, öffentlichen Verkehrsmitteln oder an Plätzen, an den viele Menschen zusammenkämen, Vorsicht walten lassen. Demonstrationen sollten vermieden werden.
Zuvor hatte bereits Interpol vor Anschlägen während der Olympischen Spiele im Sommer gewarnt. Es sei «sehr wahrscheinlich», dass El Kaida oder eine andere Extremistengruppe ein Attentat in Peking plane, sagte Interpol-Chef Ronald Noble am Freitag zu Beginn einer Sicherheitskonferenz in Peking.
Zudem seien gewaltsame Proteste und Störaktionen pro-tibetischer Demonstranten zu erwarten. Die Olympischen Spiele seien gerade wegen ihrer symbolischen Strahlkraft und des weltweiten Publikums ein strategisch reizvolles Ziel für Extremisten.
In einer Reisewarnung vom März hatte das US-Aussenministerium noch mitgeteilt, die Bedrohung von Terroristen sei minimal, jedoch sollten US-Bürger auf ihren Reise nach China dennoch wachsam sein.
http://www.whitehouse.gov/
**************************************************
...erinnnert sei dabei an die UDTT-Meldung vom 27.03.08 17:40
http://www.finanznachrichten.de/ext/goto.asp?id=10437186
Universal Detection Technology Receives Purchase Order for Anti MRSA Products From Chinese Distributor
Partner in China, With the Highest Rate of Antibiotic Resistant Bacteria, to Purchase Anti Microbial Chemical
LOS ANGELES, March 27, 2008 (PRIME NEWSWIRE) -- Universal Detection Technology (www.udetection.com) (OTCBB:UDTT) (Frankfurt:PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, and provider of counter-terrorism consulting and training services, announced today that it has received a purchase order for anti MRSA products from its Chinese distributor. The purchase order has been placed by Kadinuo Science and Technology in Beijing, China.
Kadinuo Science and Technology has been active in introduction and promotion of advanced radiation instruments in the Chinese market for over 10 years. Presently, the company is a strong regional supplier of emergency nuclear monitors, environmental radiation monitors, decontamination technologies, and the like.
"This is the second purchase order we have received from our Chinese distributor pursuant to our recent agreement. The first order was related to our line of bioterrorism detection products. We look forward to establishing an effective and long term relationship with Kadinuo and to use their influence to find a market for our products and services in China both in the counter-terrorism market and in the anti-microbial market," said Mr. Jacques Tizabi, UDTT's Chairman and CEO.
Studies show that China has the highest rate of antibiotic resistant bacteria strains in the world. The World Health Organization West Pacific Regional Office has set up two antimicrobial resistance surveillance centers in Beijing and Shanghai. Data from the offices show the prevalence of both hospital-acquired and community-acquired MRSA strains in both cities. Moreover, the breakout of Severe Acute Respiratory Syndrome (SARS) in the spring of 2003 illustrates how an infectious disease with limited therapeutic options can spread rapidly across national borders. Rapidly increasing travel and migration within China probably contributes to the growth of that nation's resistance problem. It may also spur the spread of China's resistance problems overseas as globalization greatly increases travel from and to that nation.
UDTT is a supplier of counter terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.
For more information please visit www.udetection.com or Email us at info@udetection.com
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
CONTACT: Universal Detection Technology
Jacques Tizabi
310-248-3655
Apr 30, 2008 16:05 ET
Universal Detection Technology Completes First Phase of Department of Homeland Security SAFETY Act Application for the BSM-2000
LOS ANGELES, CA--(Marketwire - April 30, 2008) -
Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it has completed the first Phase of the Department of Homeland Security's (DHS) SAFETY Act Application for the BSM-2000 airborne anthrax spore monitor. The SAFETY Act provides liability protection to help promote the creation, deployment and use of anti-terrorism technologies.
The Support Anti-terrorism by Fostering Effective Technologies Act of 2002 (SAFETY Act) provides important legal liability protections for providers of Qualified Anti-Terrorism Technologies -- whether they are products or services. The goal of the SAFETY Act is to encourage the development and deployment of new and innovative anti-terrorism products and services by providing liability protections. The SAFETY Act provides incentives for the development and deployment of anti-terrorism technologies by creating a system of "risk management" and a system of "litigation management." The purpose of the Act is to ensure that the threat of liability does not deter potential manufacturers or Sellers of anti-terrorism technologies from developing and commercializing technologies that could save lives.
"We are happy to announce the completion of the first phase of our application towards obtaining a SAFETY Act designation for the BSM-2000," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer. "The process ensures that we continue our established dialogue with the Department of Homeland Security's SAFETY Act office towards obtaining this crucial designation for our technology," he added.
UDTT is a supplier of counter-terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.
For more information please visit www.udetection.com or
Email us at info@udetection.com
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
Contact:
Jacques Tizabi
Email Contact
310-248-3655
May 02, 2008 07:01 ET
Universal Detection Technology Introduces New Line of Radiation Detectors Primarily for Use by First Responders Expanding Company's Presence in the CBRN Detection Field
Credit Card Sized Radiation Dosimeters Provide Visual Measurement of Absorbed Radiation Dose
LOS ANGELES, CA--(Marketwire - May 2, 2008) - Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter terrorism training and solutions, announced today that in its efforts to supply more comprehensive CBRN solutions, the Company is initiated the sales and marketing on credit card sized radiation dosimeters.
The new product is UDTT's RADView™ PD Dosimeter badge, a lightweight credit card size radiation dosimeter incorporating a self-developing radiochromic film to provide visual measurement of absorbed radiation dose. The film develops a distinctive and characteristic color upon exposure to ionizing radiation, becoming progressively darker in proportion to absorbed dose. RADView PD dosimeters are unaffected by brief exposures to sunlight or normal room light. The films are water-resistant, tissue equivalent, energy independent and dose-rate independent. The badges do not require calibration, maintenance, or any electronics or batteries. Under most conditions, the dosimeter can be worn for one year before replacement. A quick visual observation of a RADView PD dosimeter allows anyone to assess the absorbed dose.
"This distribution deal expands the range of products we offer to the First Responder Community and is a positive step in our efforts to become providers of complete CBRN detection technologies. The RADView dosimeter is a reliable and tested product that can be used by police, firefighters, emergency medical staff, assessment personnel, remediation crews or any practice with potential duties at an emergency site," said Jacques Tizabi, CEO of Universal Detection Technology.
Universal Detection Technology is a supplier of counter-terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in its BSM-2000, capable of autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies hand held assays for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.
The Company recently announced that it has completed the first phase of its application towards obtaining SAFETY Act designation. The Support Anti-terrorism by Fostering Effective Technologies Act of 2002 (SAFETY Act) provides important legal liability protections for providers of Qualified Anti-Terrorism Technologies, whether they are products or services. The goal of the SAFETY Act is to encourage the development and deployment of new and innovative anti-terrorism products and services by providing liability protections. The SAFETY Act provides incentives for the development and deployment of anti-terrorism technologies by creating a system of "risk management" and a system of "litigation management." The purpose of the Act is to ensure that the threat of liability does not deter potential manufacturers or Sellers of anti-terrorism technologies from developing and commercializing technologies that could save lives.
For more information please visit www.udetection.com or
Email us at info@udetection.com
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
Contact:
Jacques Tizabi
310-248-3655
Email Contact
Angehängte Grafik:
430211_prod_radview_exp_21.gif
430211_prod_radview_exp_21.gif
Angehängte Grafik:
430211_prod_radview_exp_21.gif
430211_prod_radview_exp_21.gif